| Structure |
Chemical Name |
CAS |
MF |
![L-Alanine, N-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-Methylethyl ester](/CAS/20150408/GIF/1256490-52-4.gif) |
L-Alanine, N-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-Methylethyl ester |
1256490-52-4 |
C18H17F5NO5P |
 |
P-トルエンスルホン酸2,6-ジアミノ-4-ピリミジニル3-オキシド |
75105-16-7 |
C11H12N4O4S |
 |
Vonoprazan Impurity 6 |
|
|
 |
Fluorine-Argon-Nitrogen mixture |
|
|
 |
Rabeprazole Impurity 21 |
|
|
 |
Vortioxetine Impurity 25 |
1639263-80-1 |
C18H22N2O2S |
![(R)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone](/) |
(R)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone |
|
|
 |
Butyphthalide impurity 27 |
33704-16-4 |
C12H12O5 |
 |
Sitagliptin EP Impurity 1 |
|
|
 |
(Z)-N-(2-nitrovinyl)acetaMide |
1238305-24-2 |
C4H6N2O3 |
 |
Dolutegravir Impurity 6 |
1357289-29-2 |
C20H19F2N3O5 |
 |
Cisatracurium besylate impurity 21 |
|
|
 |
2-Pyridinecarboxamide, 4-hydroxy-N-methyl- (9CI) |
611226-36-9 |
C7H8N2O2 |
 |
Ondansetron Impurity B |
|
|
 |
Aprepitant Impurity 23 |
|
|
 |
rac-Clopidogrel Carboxylic Acid Hydrochloride |
1015247-88-7 |
C15H15Cl2NO2S |
 |
Minocycline N-Hydroxymethyl Impurity |
1075240-33-3 |
C24H29N3O8 |
 |
Cefaclor EP IMpurity |
|
|
 |
Erlotinib Impurity 19 |
|
|
 |
4-Chlor-3-nitro-5-sulfobenzoesure |
130262-91-8 |
C7H4ClNO7S |
 |
2-methyl-4-(((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14- tetraen-1-yl)oxy)naphthalen-1-yl acetate |
|
|
 |
3,4-O-(DiethylMethylidene) ShikiMic Acid Ethyl Ester |
943515-58-0 |
C14H22O5 |
 |
Alogliptin Impurity C |
1108731-49-2 |
C20H23N5O3 |
 |
Ticagrelor IMpurity E |
1402150-34-8 |
C26H30F2N6O5S |
![1H-Pyrrole-3-carboxaldehyde, 1-[(5-chloro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-](/CAS/20210305/GIF/2514742-82-4.gif) |
1H-Pyrrole-3-carboxaldehyde, 1-[(5-chloro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)- |
2514742-82-4 |
C16H10ClFN2O3S |
 |
Dasatinib N-Oxide |
910297-52-8 |
C22H26ClN7O3S |
 |
PraMipexole DiMer IMpurity II |
2206826-82-4 |
C20H32N6S2 |
 |
(4S,6R)-((4R,6S)-6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl 6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxane-4-carboxylate |
|
|
 |
IRAS vials are low alkaline and meet the pharmacopoeia standards of various countries |
|
|
 |
Acetaminophen Impurity B |
98966-17-7 |
C16H16N2O4 |
 |
Linagliptin Impurity 40 |
|
|
 |
Sunitinib iMpurity E |
|
|
 |
Prucalopride Impurity F |
1900715-98-1 |
C18H26ClN3O4 |
 |
Cabozantinib impurity 39 |
|
|
 |
Peramivir Deacetyl Impurity |
|
|
 |
Carbidopa Impurity 2 |
1361017-74-4 |
C11H16N2O4 |
 |
N-(2-hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl) -N-isopropylformamide |
1447715-45-8 |
C19H31NO5 |
 |
Oseltamivir Impurity 3 |
|
|
メタノン](/CAS/GIF/105356-90-9.gif) |
[4-(4-アミノ-7-ヒドロキシ-6-メトキシ-2-キナゾリニル)-1-ピペラジニル](テトラヒドロ-2-フラニル)メタノン |
105356-90-9 |
C18H23N5O4 |
 |
3-Cyano-4-isobutoxybenzoic acid |
528607-60-5 |
C12H13NO3 |
 |
Pitavastatin Impurity 23 |
1467166-39-7 |
C28H28FNO4 |
 |
N-(4,5-ジヒドロ-1H-イミダゾール-2-イル)-6-キノキサリンアミン |
91147-43-2 |
C11H11N5 |
 |
impurity 39 |
|
|
 |
Nitrendipine iMpurity G |
|
|
 |
E-Ceftazidime Oxide Impurity |
|
|
 |
Isavuconazole Impurity 22 |
|
|
 |
Tigecycline Pentacyclic Analog |
1268494-40-1 |
C27H32N4O9 |
 |
Cefuroxime Impurity 9 |
2165460-37-5 |
C8H10N2O4S |
 |
1,4,8,11-tetraazacyclotetradecane sodium chelation |
|
|
 |
Crisaborole intermediate |
1187188-60-8 |
C14H13BO4 |
 |
Nicergoline Impurity 01 |
|
|
 |
Tenofovir Impurity W |
1244022-55-6 |
C15H24N5O8P |
 |
Tofacitinib Impurity 82 |
|
|
 |
2,2-Dimethyl-4-isopropyl-1,3-benzodioxole (Propofol Impurity L) |
201166-22-5 |
C12H16O2 |
 |
Voriconazole toxic impurity 2 |
|
|
 |
N,N'-Bis(4-hydroxyphenyl)hydrazine |
158905-63-6 |
C12H12N2O2 |
 |
Landiolol impurity S |
|
|
 |
Brexpiprazole Impurity |
2116542-21-1 |
C38H40N4O4S |
 |
Flucloxacillin Impurity A |
|
|
 |
Mirabegron Impurity 11 |
1684452-85-4 |
C21H24N4O2S |
 |
22,23-Didehydro SelaMectin |
165108-09-8 |
C43H61NO11 |
 |
Ertapenem Impurity E(USP) |
|
|
![N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide](/CAS/20210111/GIF/1628530-41-5.gif) |
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide |
1628530-41-5 |
C28H24FN3O6 |
 |
tert-butyl (R)-3-(hydroxymethyl)hexanoate |
1928755-17-2 |
C11H22O3 |
 |
Cephalexin Impurity C2 |
|
|
 |
(1R,4S)-セルトラリン塩酸塩 |
79896-32-5 |
C17H18Cl3N |
 |
Ribavirin IMpurity G |
|
|
 |
N-(4-methyl-3-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide |
|
C30H33N7O |
 |
(2R,3R,4R,5R)-2-(4-amino-2-oxo |
1415316-72-1 |
C12H16N4O7 |
 |
Bisoprolol Impurity 34 |
|
|
![5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate](/CAS/20150408/GIF/1056459-37-0.gif) |
5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
1056459-37-0 |
C20H21ClFNO3S |
 |
Dapagliflozin Impurity 4 |
960404-50-6 |
|
 |
4,4'-(2-ピリジニルメチレン)ビスフェノール |
603-41-8 |
C18H15NO2 |
 |
Sunitinib iMpurity A |
|
|
 |
(3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one |
1312077-05-6 |
C12H11NO |
![Carbonic acid, (12aR)-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl methyl ester](/CAS/20210305/GIF/1985606-48-1.gif) |
Carbonic acid, (12aR)-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl methyl ester |
1985606-48-1 |
C26H21F2N3O6S |
 |
LaMotrigine IMpurity D |
661463-79-2 |
C9H5Cl2N3O2 |
![(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2,2-dichloroacetyl) -2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate](/CAS/20180703/GIF/1598416-08-0.gif) |
(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2,2-dichloroacetyl) -2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate |
1598416-08-0 |
C22H18Cl2N2O5 |
 |
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
 |
(1-ジアゾ-2-オキソプロピル)ホスホン酸ジメチル |
90965-06-3 |
C5H9N2O4P |
 |
Imatinib Impurity 5 |
|
|
 |
Macitentan Impurity 2 |
2211054-90-7 |
C10H8Br2N4O2 |
 |
(1'S,3'S,4'S)-Entecavir IsoMer |
1367369-80-9 |
C12H15N5O3 |
 |
Cefazolin Impurity L |
|
|
 |
炭酸クロロメチルエチル |
35179-98-7 |
C4H7ClO3 |
![5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate](/CAS/20200331/GIF/949155-13-9.gif) |
5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate |
949155-13-9 |
C20H22ClNO5 |
 |
2-(3-ヒドロキシフェニル)-4-メチルチアゾール-5-カルボン酸エチル |
209538-87-4 |
C13H13NO3S |
 |
Peramivir Impurity 45 |
|
|
 |
Pyrazole |
|
|
 |
Imatinib Impurity 10 |
|
|
 |
Paris polyphylla |
|
|
![4-(6-((6-ブロモ-8-シクロペンチル-5-メチル-7-オキソ-7,8-ジヒドロピリド[2,3-D]ピリミジン-2-イル)アミノ)ピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル](/StructureFile/ChemBookStructure22/GIF/CB61010565.gif) |
4-(6-((6-ブロモ-8-シクロペンチル-5-メチル-7-オキソ-7,8-ジヒドロピリド[2,3-D]ピリミジン-2-イル)アミノ)ピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル |
571188-82-4 |
C27H34BrN7O3 |
 |
Tofacitinib Impurity K |
2328165-36-0 |
C16H21N5O3 |
 |
Empagliflozin Impurity 83 |
|
|
 |
クロロ-N-(2,4-ジメチルフェニル)アセトアミド |
39106-10-0 |
C10H12ClNO |
 |
Aprepitant impurity 1 |
|
|
![L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]tridecyl ester](/CAS/20210111/GIF/1119226-56-0.gif) |
L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]tridecyl ester |
1119226-56-0 |
C30H55NO5 |
 |
Revefenacin Impurity 21 |
|
|
 |
Nicergoline EP Impurity IJ |
|
|
 |
Celecoxib iMpurity-A |
|
|